These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23026382)

  • 1. Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy.
    Rose J; Wertheim BC; Guerrero MA
    Am J Surg; 2012 Dec; 204(6):881-6; discussion 886-7. PubMed ID: 23026382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
    Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
    Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second neoplasms after megavoltage radiation for pediatric tumors.
    Gold DG; Neglia JP; Dusenbery KE
    Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy.
    Haddy N; Andriamboavonjy T; Paoletti C; Dondon MG; Mousannif A; Shamsaldin A; Doyon F; Labbé M; Robert C; Avril MF; Fragu P; Eschwege F; Chavaudra J; Schvartz C; Lefkopoulos D; Schlumberger M; Diallo I; de Vathaire F
    Radiother Oncol; 2009 Nov; 93(2):377-82. PubMed ID: 19515442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric solid tumors and second malignancies: characteristics and survival outcomes.
    Vasudevan V; Cheung MC; Yang R; Zhuge Y; Fischer AC; Koniaris LG; Sola JE
    J Surg Res; 2010 May; 160(2):184-9. PubMed ID: 19765728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.
    Wright JD; St Clair CM; Deutsch I; Burke WM; Gorrochurn P; Sun X; Herzog TJ
    Cancer; 2010 May; 116(10):2486-92. PubMed ID: 20209618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of multiple primary breast and thyroid carcinomas.
    Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
    Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
    Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid adenomas after solid cancer in childhood.
    Haddy N; El-Fayech C; Guibout C; Adjadj E; Thomas-Teinturier C; Oberlin O; Veres C; Pacquement H; Jackson A; Munzer M; N'Guyen TD; Bondiau PY; Berchery D; Laprie A; Bridier A; Lefkopoulos D; Schlumberger M; Rubino C; Diallo I; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e209-15. PubMed ID: 22672756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second tumors in pediatric patients treated with radiotherapy to the central nervous system.
    Galloway TJ; Indelicato DJ; Amdur RJ; Swanson EL; Smith AA; Marcus RB
    Am J Clin Oncol; 2012 Jun; 35(3):279-83. PubMed ID: 21383606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of second malignancies among patients treated with proton versus photon radiation.
    Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.
    Sultan I; Rihani R; Hazin R; Rodriguez-Galindo C
    Acta Oncol; 2010; 49(2):237-44. PubMed ID: 20100158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.